Usmeritve za obravnavo zunajbolnišnične pljučnice (ZBP) odraslih

  • Ema Mušič Bolnišnica Golnik, Klinični oddelek za pljučne bolezni in alergijo, 4204 Golnik
  • Viktorija Tomič Bolnišnica Golnik, Klinični oddelek za pljučne bolezni in alergijo, 4204 Golnik
  • Peter Kecelj Bolnišnica Golnik, Klinični oddelek za pljučne bolezni in alergijo, 4204 Golnik
  • Mitja Košnik Bolnišnica Golnik, Klinični oddelek za pljučne bolezni in alergijo, 4204 Golnik
  • Renato Eržen Klinika za infekcijske bolezni in vročinska stanja, Klinični center, Japljeva 2, 1525 Ljubljana
  • Bojana Beovič Klinika za infekcijske bolezni in vročinska stanja, Klinični center, Japljeva 2, 1525 Ljubljana
  • Tatjana Lejko-Zupanc Klinika za infekcijske bolezni in vročinska stanja, Klinični center, Japljeva 2, 1525 Ljubljana
  • Franc Strle Klinika za infekcijske bolezni in vročinska stanja, Klinični center, Japljeva 2, 1525 Ljubljana
  • Vlasta Vodopivec-Jamšek Katedra za družinsko medicino, Medicinska fakulteta, Poljanski nasip 58, 1000 Ljubljana
  • Igor Švab Katedra za družinsko medicino, Medicinska fakulteta, Poljanski nasip 58, 1000 Ljubljana

Abstract

-

Downloads

Download data is not yet available.

References

Mušič E, Zupančič M, Debeljak A, Šorli J. Priporočila za diagnostiko in zdravljenje pljučnice domačega okolja. Zdrav Vestn 1997; 66: 255–60.

ERS Task Force Report. Guidelines for management of adult communityacquired lower respiratory tract infections. European Respiratory Society. Eur Respir J 1998; 11: 986–91.

Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730–54.

Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000; 31: 383–421.

Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37: 1405–33.

Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31: 347–82.

British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 2001; 56 Suppl 4: IV1–64.

Halm EA, Teirstein AS. Clinical practice. Management of community-acquired pneumonia. N Engl J Med 2002; 347: 2039–45. 9. Macfarlane JT, Boldy D. 2004 update of BTS pneumonia guidelines: what’s new? Thorax 2004; 59: 364–6.

Šorli J. Predgovor. Krka Med Farm 2003; 24: 5–6.

Mušič E. Zunajbolnišnična pljučnica v ambulantni obravnavi. Isis 2005; 14: 33–8.

Mušič E. Obravnava zunajbolnišnične pljučnice (ZBP) v bolnišnici: izhodi-šča za bodočo prenovo priporočil. Isis 2005; 14: 119–22.

Woodhead M. Community-acquired pneumonia guidelines: much guidance, but not much evidence. Eur Respir J 2002; 20: 1–3.

CAPNETZ – Kompetenznetz Ambulant erworbene Pneumonie. Dosegljivo na: http://www.capnetz.de/html/capnetz

Mušič E, Vencelj B, Bajrovič N, Eržen R, Šorli J. Hospitaly treated community-acquired pneumonia (CAP) in the elderly. Atemwegs-Lungenkr 1999; 25: 468–71.

Waterer GW, Kessler LA, Wunderink RG. Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169: 910–4.

Eržen R. Pljučnice. In: Kocijančič A, Štajer D, Mrevlje F, eds. Interna medicina, 3. izdaja. Ljubljana: Založba Littera Picta; 2005. p. 354–60.

Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243–50.

Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377–82.

Woodhead M. Assessment of illness severity in community acquired pneumonia: a useful new prediction tool? Thorax 2003; 58: 371–2.

Ewig S, de Roux A, Bauer T, Garcia E, Mensa J, Niederman M, et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004; 59: 421–7.

Marras TK, Gutierrez C, Chan CK. Applying a prediction rule to identify lowrisk patients with community-acquired pneumonia. Chest 2000; 118: 1339–43.

Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Genin R, et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 2004; 24: 779–85.

Tomič V, Svetina-Šorli P. Antimicrobial treatment of respiratory tract infections in hospital. In: Zidarn M, Košnik M, Zdolšek S, eds. Book of abstracts of the 3rd Slovenian congress of pneumology and allergology and 1st Slovenian congress of respiratory nursing. Portorož 2004: 26.

Welte T, Klante T, Piecyk A. Ambulant und nosokomial erworbene Pneumonien. Thieme-Refresher Pneumologie 2003; 1: 1–24.

File TM Jr, Garau J, Blasi F, Chidiac C, Klugman K, Lode H, et al. Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest 2004; 125: 1888–901.

Cunha BA. Empiric therapy of community-acquired pneumonia: guidelines for the perplexed? Chest 2004; 125: 1913–9.

Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56: 296–301.

Marras TK, Jamieson L, Chan CK. Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals. Can Respir J 2004; 11: 131–7.

Fok MC, Kanji Z, Mainra R, Boldt M. Characterizing and developing strategies for the treatment of community-acquired pneumonia at a community hospital. Can Respir J 2002; 9: 247–52.

Falguera M, Sacristan O, Nogues A, Ruiz-Gonzalez A, Garcia M, Manonelles A, et al. Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity. Arch Intern Med 2001; 161: 1866–72.

Luna CM, Famiglietti A, Absi R, Videla AJ, Nogueira FJ, Fuenzalida AD, et al. Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 2000; 118: 1344–54.

De Roux A, Marcos MA, Garcia E, Mensa J, Ewig S, Lode H, et al. Viral community-acquired pneumonia in nonimmunocompromised adults. Chest 2004; 125: 1343–51.

Beovic B, Bonac B, Kese D, Avsic-Zupanc T, Kreft S, Lesnicar G, et al. Aetiology and clinical presentation of mild community-acquired bacterial pneumonia. Eur J Clin Microbiol Infect Dis 2003; 22: 584–91.

Lieberman D, Lieberman D, Porath A. Seasonal variation in communityacquired pneumonia. Eur Respir J 1996; 9: 2630–4.

Waterer GW, Jennings SG, Wunderink RG. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 1999; 116: 1278–81.

Chalasani NP, Valdecanas MA, Gopal AK, McGowan JE Jr, Jurado RL. Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest 1995; 108: 932–6.

Metersky ML, Ma A, Bratzler DW, Houck PM. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169: 342–7.

Campbell SG, Marrie TJ, Anstey R, Dickinson G, Ackroyd-Stolarz S. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 2003; 123: 1142–50.

Smith PR. What diagnostic tests are needed for community-acquired pneumonia? Med Clin North Am 2001; 85: 1381–96.

Cunha BA. Ambulatory community-acquired pneumonia: the predominance of atypical pathogens. Eur J Clin Microbiol Infect Dis 2003; 22: 579–83.

Tomič V, Šorli J. Diagnostična vrednost razmaza sputuma in endotrahealnega aspirata, obarvanega po Gramu. Zdrav Vestn 2002; 71: 83–6.

Mušič E, Tomič V. Mikrobiološka analiza kužnin pri pljučnicah in možne napake. In: Dragaš AZ, Fišer J, Prinčič D, et al., eds. Zbornik strokovnega srečanja Mikrobiološka analiza kužnin. Nova Gorica 1999: 165–72.

Templeton KE, Schelting SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of communityacquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005; 41: 345–51.

Korošec P, Eržen R, Šilar M, Košnik M. PCR for detection of atypical pathogens causing pneumonia. In: Zidarn M, Košnik M, Zdolšek S, eds. Book of abstracts of the 3rd Slovenian congress of pneumology and allergology and 1st Slovenian congress of respiratory nursing. Portorož 2004: 23.

Mušič E. Sodobna obravnava pljučnice pri starostniku. In: Fras Z, Poredoš P, Vrtovec B, et al., eds. Zbornik prispevkov. 46. Tavčarjevi dnevi. Portorož 2004: 243–54.

Janssens JP, Gauthey L, Herrmann F, Tkatch L, Michel JP. Communityacquired pneumonia in older patients. J Am Geriatr Soc 1996; 44: 539–44.

El-Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001; 163: 645–51.

Ewig S, Magnussen H. The diagnosis of pneumonia in daily practice: how many diagnostic measures are essential? Dtsch Med Wochenschr 2001; 126: 1373–8.

Torres A, Woodhead M, eds. Pneumonia. Eur Respir Mon. 1997; 2: 1–262.

Rozman A, Mušič E. Bacteremic pneumonia: etiology, treatment and outcome. In: Zidarn M, Košnik M, Zdolšek S, eds. Book of abstracts of the 3rd Slovenian congress of pneumology and allergology and 1st Slovenian congress of respiratory nursing. Portorož 2004: 21.

Marrie TJ, Low DE, De Carolis E, Canadian Community-Acquired Pneumonia Investigators. A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology – results from a Canadian multicentre study. Can Respir J 2003; 10: 368–74.

www.earss.rivm.nl/PAGINA/interwebsite/home_earss.html

Mušič E in delovna skupina za obravnavo respiracijskih infekcij KOPA Golnik. Temelji novih priporočil obravnave zunajbolnišnične pljučnice v Sloveniji, Strokovni posvet »Celosten pristop obravnave pljučnic domačega okolja«. Ljubljana: IVZ RS 2005.

Cazzola M, Blasi F, Ewig S, eds. Antibiotics and the lung. Eur Respir Mon 2004; 9: 1–267.

Peršin M, Mrhar A, Košnik M, Osolnik K, Jošt M. Analysis of antibiotic therapy of lower respiratory tract infections. In: Zidarn M, Košnik M, Zdolšek S, eds. Book of abstracts of the 3rd Slovenian congress of pneumology and allergology and 1st Slovenian congress of respiratory nursing. Portorož 2004: 28.

Arancibia F, Ewig S, Martinez JA, Ruiz M, Bauer T, Marcos MA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med 2000; 162: 154–60.

Lim WS. Identifying failure of empirical treatment for pneumonia: vigilance and common sense. Thorax 2004; 59: 918–9.

Menendez R, Cremades MJ, Martinez-Moragon E, Soler JJ, Reyes S, Perpina M. Duration of length of stay in pneumonia: influence of clinical factors and hospital type. Eur Respir J 2003; 22: 643–8.

Goss CH, Rubenfeld GD, Park DR, Sherbin VL, Goodman MS, Root RK. Cost and incidence of social comorbidities in low-risk patients with communityacquired pneumonia admitted to a public hospital. Chest 2003; 124: 2148–55.

Sočan M, Kraigher A. Preprečevanje pnevmokoknih okužb s cepljenjem. Zdrav Var 2000; 39: 5–31.

How to Cite
1.
Mušič E, Tomič V, Kecelj P, Košnik M, Eržen R, Beovič B, Lejko-Zupanc T, Strle F, Vodopivec-Jamšek V, Švab I. Usmeritve za obravnavo zunajbolnišnične pljučnice (ZBP) odraslih. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];74(12). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/2256
Issue
Vol 74 No 12 (2005): December
Section
Quality and safety


The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.

The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory

The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.

The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.

The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.